-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Arena Capital Advisors LLC CA Reduces Stock Position in European Biotech Acquisition Corp. (NASDAQ:EBAC)
Arena Capital Advisors LLC CA Reduces Stock Position in European Biotech Acquisition Corp. (NASDAQ:EBAC)
Arena Capital Advisors LLC CA lowered its holdings in shares of European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 94.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 5,717 shares of the company's stock after selling 98,025 shares during the quarter. Arena Capital Advisors LLC CA's holdings in European Biotech Acquisition were worth $56,000 as of its most recent filing with the Securities & Exchange Commission.
European Biotech Acquisition Price Performance
European Biotech Acquisition stock remained flat at $9.99 during mid-day trading on Friday. 52,698 shares of the company traded hands, compared to its average volume of 30,297. European Biotech Acquisition Corp. has a one year low of $9.66 and a one year high of $10.50. The stock's 50 day moving average is $9.94.
Get European Biotech Acquisition alerts:European Biotech Acquisition Company Profile
(Get Rating)
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.Read More
- Get a free copy of the StockNews.com research report on European Biotech Acquisition (EBAC)
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
Want to see what other hedge funds are holding EBAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating).
Receive News & Ratings for European Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for European Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Arena Capital Advisors LLC CA lowered its holdings in shares of European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating) by 94.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 5,717 shares of the company's stock after selling 98,025 shares during the quarter. Arena Capital Advisors LLC CA's holdings in European Biotech Acquisition were worth $56,000 as of its most recent filing with the Securities & Exchange Commission.
Holdings Channel.com报道，Arena Capital Advisors LLC CA在第二季度将其持有的欧洲生物技术收购公司（纳斯达克股票代码：EBAC — 获取评级）的股票下调了94.5％。该公司在本季度出售了98,025股股票后，拥有该公司的5,717股股票。截至最近向美国证券交易委员会提交的文件，Arena Capital Advisors LLC CA在欧洲生物技术收购中的持股价值56,000美元。
European Biotech Acquisition Price Performance
欧洲生物技术收购价格表现
European Biotech Acquisition stock remained flat at $9.99 during mid-day trading on Friday. 52,698 shares of the company traded hands, compared to its average volume of 30,297. European Biotech Acquisition Corp. has a one year low of $9.66 and a one year high of $10.50. The stock's 50 day moving average is $9.94.
周五午盘交易中，欧洲生物技术收购股票持平至9.99美元。该公司有52,698股交易，而平均交易量为30,297股。欧洲生物技术收购公司创下了9.66美元的一年低点和10.50美元的一年高点。该股的50天移动平均线为9.94美元。
European Biotech Acquisition Company Profile
欧洲生物技术收购公司简介
(Get Rating)
（获取评分）
Read More
阅读更多
- Get a free copy of the StockNews.com research report on European Biotech Acquisition (EBAC)
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- 免费获取 StockNews.com 关于欧洲生物技术收购 (EBAC) 的研究报告
- 石油是股票抛售尚未结束的令人信服的原因
- 在第三季度井喷报告之后，Mid-cap Neurocrine Biosciences 值得买入吗？
- Six Flags 是一款你不想被困的游乐设施
- Hanesbrands 可能预示着零售股将迎来糟糕的一周
- Vision Hydrogen，现为Vision Energy，将
Want to see what other hedge funds are holding EBAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for European Biotech Acquisition Corp. (NASDAQ:EBAC – Get Rating).
想看看还有哪些对冲基金持有 EBAC 吗？ 访问Holdingschannel.com，获取欧洲生物技术收购公司（纳斯达克股票代码：EBAC — 获取评级）的最新13F文件和内幕交易。
Receive News & Ratings for European Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for European Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收有关欧洲生物技术收购的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯，获取欧洲生物技术收购及相关公司的最新新闻和分析师评级的简要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧